Key points are not available for this paper at this time.
The Synuclein-One study is an NIH-funded 30-site trial that included 33 participants with pure autonomic failure (PAF). We report the detection and quantitation of cutaneous phosphorylated alpha-synuclein (P-SYN) in patients with suspected PAF.
Freeman et al. (Tue,) studied this question.